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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S396Purpose: To examine the associations of elevated serum c-reactive
protein (CRP) and erythrocyte sedimentation rate (ESR) with radio-
graphic progression in patients with established knee osteoarthritis
(OA), over two years.
Methods: Data from 186 patients with knee OA were gathered at
baseline and at two-years follow up. CRP (mg/l) and ESR (mm/l) were
measured in serum from patients’ blood. Inﬂammatory markers were
considered elevated if CRP>3mg/l or ESR20mm/h (1). Radiographs of
the knees were used to assess joint space narrowing (JSN), ostephytes,
sclera and cysts in the tibiofemoral (medial and lateral) and patellofe-
moral compartments, Kellgren and Lawrence (KL) score (0-4) was also
determined. Progression was deﬁned as an increase in 1 in the
radiographic features assessed or total KL score in either knee during
follow-up. The association of inﬂammatory markers with radiographic
progression was analyzed using uni- and multivariate linear regression
models. Full models were adjusted for age, gender, NSAIDs use, BMI
change, comorbidities change and higher radiographic feature or KL
score at baseline.
Results: Patients with elevated CRP and ESR values at both baseline and
two-years follow-up exhibited no progression in KL score compared
with the group with not elevated values at both times of assessment,
before or after adjustment for relevant confounders. When analyzing
the various futures (JSN, ostephytes, sclera and cysts),a signiﬁcant
association was found only between elevated CRP (OR¼2.9, p¼0.048)
and ESR (OR¼4.42, p¼0.017) values at both times of assessment and JSN
progression in the patellofemoral compartment compared with the
group with not elevated levels. No association was found between
elevated values of CRP and ESR at baseline and at follow-up with
radiographic progression of the other features analyzed in the three
compartments assessed.
Conclusions: Overall this study provides no evidence that persistently
elevated CRP and ESR values are related to a radiographic progression in
patients with established knee OA, over two years. Our results are in
line with previous evidence which has suggested no association
between elevated inﬂammatory markers and progression of OA (2).
Future studies should be performed analyzing this association with
local markers of inﬂammation, instead of systemic inﬂammatory
markers. Additionally, considering the slow progression of the disease, a
longer follow-up period might be recommended.
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SHOE TORSIONAL RESISTANCE RELATED TO MEDIAL KNEE OA
R.H. Lidtke, N. Shakoor, M. Wimmer, J.A. Block. Rush Univ. Med. Ctr.,
Chicago, IL, USA
Purpose: Recent evidence suggests that footwear can signiﬁcantly
affect dynamic knee loading and that ﬂat, ﬂexible shoes may result in
lower knee loads compared to more supportive, stiff-soled shoes. Here,
we evaluate the torsional stiffness of the shoe compared longitudinal
effects on knee loading over 6 months.
Methods: Subjects with radiographic (KL grades  2) and symptomatic
(at least 30mm pain of 100mm scale while walking) medial compart-
ment knee OAwere recruited and randomized to receive a ﬂexible soled
shoe (mobility shoe) or identical appearing “control” shoe with stiffer
sole. The frontal plane torsional stiffness of the shoe was evaluated
using a biomaterial testing system. Investigators and participants were
blinded to shoe assignment. Baseline gait analyses were performed
using an optoelectronic camera system and multi-component force
plate in subjects’ “own shoes”, study shoes, and barefoot. Subjects were
instructed to wear the study shoes at least 6 hours/day for 6 days/week.
Gait analysis was repeated at 6, 12 and 24 weeks. The peak knee
adduction moment (KAM), a validated marker of medial compartment
loading, was evaluated. An intent-to-treat analysis was performed with
imputation of missing data using a hot deck method (Rubin, 1987).
Repeated measures analysis of variance compared the two arms andplanned contrasts were used to further analyze the data and load
reductions at various time points.
Results: 22 participants (13 women, mean age 557 years) were
assigned to the mobility shoe and 28 (21 women, mean age 558 years)
to the control shoe. The median modulus of elasticity of the treatment
group shoes was 0.250.07 compared to the control shoe 0.941.05
(p¼0.009). There was a strong correlation between the reduction in the
KAM and torsional stiffness from baseline to 24 months in treatment
group and control group (0.88 and 0.89 respectively p¼0.03) There
were differences in Peak KAM over time in the treatment group vs.
control with the more ﬂexible shoe producing reductions while the
control increased moments (-0.25 0.95 and 0.09 0.95 %BW*ht
respectively, rmANOVA, p¼0.002).
Conclusions: This double-blind randomized controlled trial suggests
that loading of the medial knee is directly related to the torsional
stiffness the shoe. The use of shoes with ﬂexibility in the frontal plane
over 6 months results in signiﬁcant reductions in medial knee loading
compared to stiffer shoes with greater torsional resistance. Thus, eval-
uating the shoe for torsional resistance may help determine which shoe
would be an effective biomechanical intervention for the management
of knee OA.
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INTRA-ARTICULAR INJECTION THERAPY FOR PATIENTS WITH HIP
OSTEOARTHRITIS. A SYSTEMATIC REVIEW OF THE LITERATURE
S. Colen y, A. van den Hazel y, M. Mulier y, M. van den Bekerom z,
D. Haverkamp x. yUniv. Hosp. Leuven, Leuven, Belgium; zOnze Lieve
Vrouwe Gasthuis, Dept. of Orthopaedic Surgery, Amsterdam,
Netherlands; x Slotervaart Hosp., Dept. of Orthopaedic Surgery,
Amsterdam, Netherlands
Purpose: In current systematic review we will compare the efﬁcacy of
several intra-articular treatment options (CS, HA, PRP and placebo) in
patients with hip OA. The goal of this review is to give recom-
mendations regarding the most optimal treatment(s) of these patients
and formulate some recommendations for future research.
Methods: The following databases were searched: MEDLINE (period
1966 to June 2013), Cochrane Database of Systematic Reviews (1988 to
June 2013), Cochrane Clinical Trial Register (1988 to June 2013), EMBASE
(January 1988 to June 2013) and the WHO clinical trial register to
identify all articles concerning the intra-articular injection therapy for
hip OA.Search term (‘Hyaluronic Acid/administration and dosage’
[MeSH] OR ‘Hyaluronic Acid/diagnostic use’ [MeSH] OR ‘Hyaluronic
Acid/therapeutic use’ [MeSH] OR ‘Hyaluronic Acid/therapy’ [MeSH]) OR
corticosteroids OR platelet rich plasma OR stem cells AND hip)
Results: Of the 1781 studies found using the search terms mentioned
above, 36 were screened for eligibility. We included 10 RCTs (1 com-
pared CS and HA, the other compared CS or HA with different amounts
of CS, with other brands of HA, placebo and/or intra-articular admin-
istered anaesthetics) and 26 cohort series (23 HA, 1 CS ,2 PRP). Most
studies determined the efﬁcacy of intra-articular administered HA (29
papers). The efﬁcacy of intra-articular CS and PRP were studied in 7 and
2 papers, respectively. No studies were found about the use of intra-
articular mesenchymal stem cells or other treatments in patients with
hip OA. In 6 studies the results of patient treated with placebo were
reported. Of the 36 available studies 32 could be used to calculate the
effect sizes. Only the effect sizes of the treatments reported in the
studies of Flanagan et al and Migilore et al (2005) could not be calcu-
lated due to the lack of reporting data. The study of Conrozier et al
(2009) could not be used for pooling due to different durations of fol-
low-up of the patients and the study of Conrozier et al (2006) showed
the results of the same patients reported in the study of Conrozier et al
(2003). The treatment results of a total of 1979 patients could be used in
this review (499 CS, 1261 HA, 159 placebo and 60 PRP).In ﬁgure 1-4 the
calculated effect sizes of the different treatments, including placebo, at
different follow-up are shown.
Pooling the data of the different treatment options showed besides a
large heterogeneity regarding product of treatment, treatment regime
and outcome parameters also different follow-up time-points. For this
reason we decided to combine time-points 4 and 6 weeks and 8 and 12
weeks. Using these periods of follow-up we were able to compare the
effect sizes of the different treatments as shown in table 1 and 2.
Conclusion: Comparing the efﬁcacies of different treatments in
patients with hip OA at 4-6 weeks and 8-12 weeks we showed no
statistical differences. The differences in efﬁcacy between the treatment
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come for HA. The same conclusion can be made comparing HA and CS
with placebo (in favour of both HA and CS) and high molecular weight
HA compared with low molecular weight HA in the treatment of
patients with hip OA (in favour of high molecular weight HA). We
believe that the main reason for this, is the fact that there is a lack of
power of included studies/patients. Especially comparing an active
treatment with placebo.
Larger randomized controlled trials performed in the future (including
the results of our own study comparing 315 patients with hip OA
treated with either intra-articular administered HA, CS or placebo) will
give us better information about the most favourable treatment.
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COMPARISON OF TWO HYALURONIC ACID FORMULATIONS FOR
SAFETY AND EFFICACY (CHASE) STUDY OF KNEE OSTEOARTHRITIS:
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, 26 WEEK NON-
INFERIORITY TRIAL COMPARING DUROLANE TO ARTZ
H. Zhang y, K. Zhang z, X.l. Zhang x, Z.a. Zhu k, S.g. Yan{, T.s. Sun#,
A. Guo yy, J.T. Jones zz, G. Steen zz, H.q. Zhang xx, B. Shan xx, J.h. Lin y.
y Peking Univ. People’s Hosp., Beijing, China; z Peking Univ. Third Hosp.,
Beijing, China; x Shanghai 6th People’s Hosp., Shanghai, China;
k Shanghai 9th People’s Hosp., Shanghai, China; { The Second Afﬁliated
Hosp. of Zhejiang Univ. Sch. of Med., Zhejiang, China; #Beijing Military
Gen. Hosp., Beijing, China; yyBeijing Friendship Hosp., Beijing, China;
zzBioventus LLC, Durham, NC, USA; xx Tigermed Consulting Co., Ltd.,
Beijing, China
Purpose: To compare efﬁcacy and safety of intra-articular hyaluronic
acid (HA) in two formulations: one 3.0ml injection of Durolane vs ﬁve
2.5ml injections of ARTZ for the treatment of knee osteoarthritis pain.
Methods: Subjects (N¼349) from the People’s Republic of China were
randomized to treatment (Durolane¼175, ARTZ¼174). The Durolane
group received 3.0ml at week 0 (baseline), with sham skin punctures at
weeks 1, 2, 3, and 4. The ARTZ group received one 2.5ml injection at
each of the same time points. The primary assessment was a Likert pain
scale (Western Ontario and McMaster University scale, WOMAC). Sec-
ondary assessments included WOMAC scales of physical function and
knee stiffness, and global self-evaluationat weeks 0, 6, 10, 14, 18, and 26.
The primary analysis was non-inferiority of Durolane over 18 weeks,
with secondary analysis over 26 weeks, with a priori non-inferiority
deﬁned as 8% of the respective scale. Only acetaminophen was per-
mitted as rescue analgesia and all adverse events (AEs) were recorded.
Results: Overall study retention was excellent; 332 (95.1%) subjects
completed 18 weeks and 319 (91.4%) completed 26 weeks, with no
signiﬁcant retention difference between treatment arms. All variables
met non-inferiority criteria over 18 and 26weeks and efﬁcacy response
was >90%. Treatment-related AEs were 9.8% (17/174) for Durolane and
13.1% (23/175) for ARTZ.
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IS THE SURGICAL EPICONDYLAR AXIS A SUBSTITUTE FOR THE
FLEXION- EXTENSION AXIS?
H. Kobayashi, Y. Akamatsu, K. Kumagai, Y. Kusayama, T. Saito. Yokohama
City Univ., Sch. of Med., Yokohama, Kanagawa, Japan
Purpose: The importance of rotational alignment of the femoral com-
ponent for total knee arthroplasty (TKA) has been widely recognized
because it has a direct inﬂuence on the ﬂexion gap and balance and
patella tracking. The surgical epicondylar axis (SEA) is one of reliable
landmarks for properly rotating the femoral component in the axial
plane. We previously reported that the SEA was a reliable surgical
landmark in the coronal plane as well as in the axial plane. However, the
balance and the gap might be asymmetric at several points between 0
of extension and 90 of ﬂexion, even if they are appropriate for both 0
and 90. The soft tissue imbalance and gap asymmetry has been
observed in the midrange using a tensor in TKAs. The aims of the study
were to measure the distances between the SEA and the margin of the
medial / lateral femoral condyles at 0, 30, 60, 90, and 120 of ﬂexion
and to investigate whether the SEA could be used as the rotational axis
of the knee. Additionally, comparisons were made according to gender.
Methods: A total of 60 knees in 54 patients with osteoarthritis under-
going TKA or high tibial osteotomywere enrolled. The patients included
28 men and 26 women with a mean age of 67.6 years. A preoperativecomputed tomography (CT) images (SOMATOM Sensation 16, Siemens,
Munich, Germany) of the whole lower extremity with 1.5mm slice
thickness were incorporated into Orthomap3D (Stryker, Kalamazoo,
MI), which enabled us to select anatomical landmarks and determine
three-dimensional linear and angular measurements by simultaneously
referring to the sagittal, coronal, and axial planes. The SEA was deﬁned
as a line connecting the sulcus of the medial epicondyle and the lateral
epicondylar prominence, and this line was designated as the X- axis.
The Y- axis was deﬁned as a line drawn perpendicularly from the center
of the femoral head to the X- axis. The Z- axis was deﬁned as the cross
product of the X- and Y- axes. The distance between the SEA and the
margin of the lateral femoral condyles (LD) at 0 , 30 ,60 , 90 , and 120
of ﬂexion and the distance between the SEA and the margin of the
medial femoral condyles (MD) at 0, 30, 60, 90, and 120 of ﬂexion
were measured. The measurement deviations among each angle were
compared using one-way analysis of variance with the post hoc Tukey-
Kramer test for multiple post hoc group comparisons. Comparisons
were made according to gender using the Mann-Whitney’s U test. P
values of <0.05 were considered statistically signiﬁcant.
Results: The mean LDwith knee at 0, 30, 60, 90 , and 120 were 24.8,
24.2, 24.3, 23.3 and 21.1 mm, respectively. The mean MD at these same
degrees were 25.7, 25.2, 26.1, 25.7 and 23.1 mm, respectively. There
were no signiﬁcant differences in linear measurements among 0, 30 ,
60, and 90 . However, signiﬁcant differences were observed between
each linear measurement at 0, 30, 60, and 90 and the linear
measurement at 120 (p<0.001). Both medial and lateral linear meas-
urements at each degree were statistically different between genders
(p<0.01).
Conclusions: The relationship between the SEA and the rotational axis
of the distal femur remains unclear. Several studies have shown that the
ﬁxed ﬂexion extension axis coincided with the SEA. The morphologic
study of the distal femur showed that the arc of the femoral condyles
that ﬁtted a circle was from 0 to 90 of knee ﬂexion. It was not applied in
deep ﬂexion beyond 90 and the most posterior aspects of the femoral
condyles were no longer circular. On the contrary, the condyles were
reported to be cylindrical in shape between 20 and 120. In our study,
the distances between the SEA and the margin of the medial/lateral
femoral condyles were signiﬁcantly identical at 0 , 30, 60, and 90 of
ﬂexion with the exception of the distance at 120. This study assists
understanding of knee kinematics and provides useful information for
the design and positioning of TKA.
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LOWER PROLIDASE LEVELS ARE EXPRESSED BY SYNOVIAL TISSUE OF
KNEE OSTEARTHRITIS PATIENTS
A. Lopez Macay, L. Ventura Ríos, C. Pineda Villase~nor,
C. Hernandez Díaz, K. Silva Luna, A. Lopez Reyes. Inst. Natl. de
Rehabilitacion, D.F., Mexico
Purpose: To evaluate the role of prolidase levels as the enzyme
responsible for the recycling of the collagen in synovial tissue
Methods: the expression of synovial prolidase and the degree of
synovial neovascularization in a group of 20 consecutive knee OA
patients undergoing total knee arthroplasty was comapared, with a
control group of 20 patients undergoing knee arthroscopy for
internal derangement of the knee. A knee power Doppler ultra-
sound (PD) was done for all patients and controls before surgery to
identify areas of hypervacularization to establish the best biopsy
sampling site. Immunohistochemistry was performed with antibody
anti - factor VIII to identify vascular endothelial cells and to
compare them with power Doppler ﬁndings. Finally, the anti -
prolidase antibody immunoﬂuorescence assay was used to identify
and to semi-quantitatively evaluate the enzyme expression. Images
were captured on a cell Floid epiﬂuorescence system and analyzed
with the image J software and data expressed as arbitrary ﬂuo-
rescence units (AFU).
Results: Patients with OA had a mean age of 70  7.7 years, while the
control group had 36.3  9.8 years. The prolidase enzyme identiﬁed in
the synovial tissue of OA patients was signiﬁcantly lower when com-
pared with the control group (0.017  0.009 vs 0.062  0.04 UAF
respectively p< 0.05). The presence of PD signal was higher for patients
with OA, this increase correlated with the number of microvessels
identiﬁed in tissue samples (11 þ 5.3 vs 4 þ 2.1, p ¼ 0.003).
Conclusions: The decreased expression of prolidase enzyme present in
the synovium of OA patients is perhaps linked to a loss of extracellular
